Background and purpose: To assess the predictive value of T2 lesions on the rate of progression of disability in multiple sclerosis (MS). Methods: We reanalyzed T2 lesion number and load on brain MRI scans, performed before 1997, of 186 MS patients, who were clinically followed. There were 90 patients with progressive MS (35 secondary progressive and 55 primary progressive), and 96 with relapsing remitting MS. The rate of progression of disability was measured by time to sustained progression of disability (defined as an increase in >= 1 point when the Expanded Disability Status Scale (EDSS) was 5.5 or less and an increase in EDSS of >= 0.5 point when the EDSS was 6.0 or higher), and by the Multiple Sclerosis Severity Score (MSSS). Results:...
Wybrecht, Delphine Reuter, Francoise Zaaraoui, Wafaa Faivre, Anthony Crespy, Lydie Rico, Audrey Mali...
Background: Effective therapeutic strategies to preserve function and delay progression in multiple ...
Multiple sclerosis is a long-term disease that evolves over a period of 30 to 40 years with progress...
Background and purpose:To assess the predictive value of T2 lesions on the rate of progression of di...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstemor spinal cord syndromes are f...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstem or spinal cord syndromes are ...
Background and purpose: To predict disability and cognition in multiple sclerosis (MS) after 6 and 1...
OBJECTIVES: To explore the relationship between slowly expanding lesions (SELs) on MRI and disabilit...
BACKGROUND AND PURPOSE: Multiple sclerosis (MS) is a demyelinating disease most often associated wit...
BACKGROUND: Methodological challenges limit the use of brain atrophy and lesion burden measures in t...
OBJECTIVE: To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinica...
Patients with relapsing-remitting multiple sclerosis (MS) are at risk of converting to a secondary p...
Multiple sclerosis (MS) is primarily an inflammatory and degenerative disease of the central nervous...
Objective: The objective of the study was to determine whether early infratentorial and/or spinal co...
Objective: Magnetic resonance imaging (MRI) and clinical parameters are associated with disease prog...
Wybrecht, Delphine Reuter, Francoise Zaaraoui, Wafaa Faivre, Anthony Crespy, Lydie Rico, Audrey Mali...
Background: Effective therapeutic strategies to preserve function and delay progression in multiple ...
Multiple sclerosis is a long-term disease that evolves over a period of 30 to 40 years with progress...
Background and purpose:To assess the predictive value of T2 lesions on the rate of progression of di...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstemor spinal cord syndromes are f...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstem or spinal cord syndromes are ...
Background and purpose: To predict disability and cognition in multiple sclerosis (MS) after 6 and 1...
OBJECTIVES: To explore the relationship between slowly expanding lesions (SELs) on MRI and disabilit...
BACKGROUND AND PURPOSE: Multiple sclerosis (MS) is a demyelinating disease most often associated wit...
BACKGROUND: Methodological challenges limit the use of brain atrophy and lesion burden measures in t...
OBJECTIVE: To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinica...
Patients with relapsing-remitting multiple sclerosis (MS) are at risk of converting to a secondary p...
Multiple sclerosis (MS) is primarily an inflammatory and degenerative disease of the central nervous...
Objective: The objective of the study was to determine whether early infratentorial and/or spinal co...
Objective: Magnetic resonance imaging (MRI) and clinical parameters are associated with disease prog...
Wybrecht, Delphine Reuter, Francoise Zaaraoui, Wafaa Faivre, Anthony Crespy, Lydie Rico, Audrey Mali...
Background: Effective therapeutic strategies to preserve function and delay progression in multiple ...
Multiple sclerosis is a long-term disease that evolves over a period of 30 to 40 years with progress...